BWM
CVS icon

Baystate Wealth Management’s CVS Health CVS Stock Holding History

Baystate Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$360K Sell
4,562
-2,336
-34% -$166K 0.03% 163
2023
Q3 		$482K Buy
6,898
+363
+6% +$25.7K 0.04% 134
2023
Q2 		$452K Buy
6,535
+1,190
+22% +$84.7K 0.04% 137
2023
Q1 		$397K Sell
5,345
-84
-2% -$7.04K 0.03% 143
2022
Q4 		$506K Buy
5,429
+1,478
+37% +$143K 0.05% 143
2022
Q3 		$377K Buy
3,951
+16
+0.4% +$1.58K 0.04% 142
2022
Q2 		$365K Buy
3,935
+15
+0.4% +$1.46K 0.04% 137
2022
Q1 		$397K Buy
3,920
+156
+4% +$16.4K 0.04% 132
2021
Q4 		$388K Buy
3,764
+2,103
+127% +$194K 0.04% 126
2021
Q3 		$141K Buy
1,661
+39
+2% +$3.27K 0.01% 180
2021
Q2 		$135K Buy
1,622
+3
+0.2% +$246 0.01% 181
2021
Q1 		$122K Buy
1,619
+122
+8% +$8.89K 0.01% 174
2020
Q4 		$102K Sell
1,497
-489
-25% -$31.8K 0.01% 171
2020
Q3 		$116K Sell
1,986
-190
-9% -$11.8K 0.01% 144
2020
Q2 		$141K Buy
2,176
+78
+4% +$4.91K 0.02% 136
2020
Q1 		$124K Sell
2,098
-8
-0.4% -$534 0.02% 126
2019
Q4 		$156K Buy
2,106
+897
+74% +$63K 0.02% 133
2019
Q3 		$76K Buy
1,209
+1
+0.1% +$59 0.01% 177
2019
Q2 		$66K Buy
1,208
+1
+0.1% +$54 0.01% 184
2019
Q1 		$64K Hold
1,207
– – 0.01% 185
2018
Q4 		$79K Sell
1,207
-359
-23% -$26.8K 0.01% 159
2018
Q3 		$124K Buy
1,566
+368
+31% +$26.3K 0.02% 110
2018
Q2 		$81K Hold
1,198
– – 0.01% 144
2018
Q1 		$79K Sell
1,198
-142
-11% -$10.2K 0.01% 140
2017
Q4 		$108K Sell
1,340
-104
-7% -$7.56K 0.02% 123
2017
Q3 		$107K Buy
1,444
+192
+15% +$15.2K 0.02% 115
2017
Q2 		$98K Buy
1,252
+7
+0.6% +$553 0.02% 114
2017
Q1 		$97K Buy
1,245
+813
+188% +$64.9K 0.02% 118
2016
Q4 		$34K Buy
+432
New +$35K 0.01% 178
2013
Q3 		– Sell
-75
Closed -$4K – 64
2013
Q2 		$4K Buy
+75
New +$4.34K ﹤0.01% 236

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baystate Wealth Management's CVS Position: Q4 2023 in Review

Baystate Wealth Management reduced its CVS Health (CVS) stake by 34% in Q4 2023, selling an estimated $166K and leaving 4,562 shares worth $360K. The position accounts for 0.03% of the portfolio, ranked #163.

Baystate Wealth Management first reported a position in CVS in Q2 2013 and has held it in 30 quarters since. The position peaked at $506K in Q4 2022. 2,257 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

  • Baystate Wealth Management held 4,562 shares of CVS Health worth $360K as of Q4 2023.
  • Baystate Wealth Management sold 2,336 CVS Health shares in Q4 2023, an estimated $166K.
  • CVS Health made up 0.03% of Baystate Wealth Management's portfolio in Q4 2023, its #163 holding.
  • Baystate Wealth Management first reported a position in CVS Health in Q2 2013 and has held it in 30 quarters since.
  • Baystate Wealth Management's CVS Health position peaked at $506K in Q4 2022.
  • 2,257 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.